Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04923334 · ClinicalTrials.gov registry record · Phase 3
Nonpharmacologic Pain Management in FQHC Primary Care Clinics
A Phase 3 study of Chronic Pain and Low Back Pain, sponsored by University of Utah.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 500
- Enrollment target
- 2
- Study locations
NCT04923334: Recruiting Phase 3 study of Chronic Pain and Low Back Pain, sponsored by University of Utah.
NCT04923334 is a Phase 3 study of Chronic Pain and Low Back Pain that is actively recruiting participants, run by University of Utah. The registered enrollment target is 500 participants, below the 771-participant average among 301 other Chronic Pain trials with a reported enrollment target (35% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04923334, a Phase 3 study of Chronic Pain and Low Back Pain, is actively recruiting participants, sponsored by University of Utah.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 500 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this study is to improve pain management and reduce opioid reliance for patients with chronic back pain in Utah Federally-Qualified Health Centers (FQHCs). The study compares the effectiveness of nonpharmacologic pain treatments using telehealth to overcome access barriers. We will use automated EHR reminders for electronic referral to teleconsult services. Our project tests adaptive treatments and uses a hybrid type I design - focused on effectiveness outcomes while gathering implementation data to inform future efforts to scale effective strategies.
Primary Outcome
The PEG-3 measure includes 3 items evaluating 1) pain severity, and interference of pain with 2) enjoyment and 3) general activity. Item response options range from 0-10. The PEG-3 score is expressed as the mean of all item scores with higher scores indicating greater pain impact
Conditions Studied
Interventions
- BEHAVIORAL Brief Pain Teleconsult
- BEHAVIORAL Telehealth Physical Therapy
Study Locations (2)
Utah
- Association of Utah Community Health - Salt Lake City
- The University of Utah Healthcare System - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2021-11-04 |
| Est. Completion | 2026-06-21 |
| Phase | Phase 3 |
What NCT04923334 shows while recruiting
NCT04923334 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 771-participant average among 301 other Chronic Pain trials with a reported enrollment target (35% lower).
The record links to 2 conditions, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which Brief Pain Teleconsult is the first listed.
NCT04923334 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT04923334 about?
NCT04923334 is a clinical study titled "Nonpharmacologic Pain Management in FQHC Primary Care Clinics". The goal of this study is to improve pain management and reduce opioid reliance for patients with chronic back pain in Utah Federally-Qualified Health Centers (FQHCs). The study compares the effectiveness of nonpharmacologic pain treatments using telehealth to overcome access barriers. We will use a...
What is the current status of trial NCT04923334?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 500 participants. The study started on 2021-11-04. Estimated completion is 2026-06-21.
What conditions does trial NCT04923334 study?
This clinical trial studies the following conditions: Chronic Pain, Low Back Pain.
What interventions are being tested in trial NCT04923334?
The interventions under investigation include: Brief Pain Teleconsult (BEHAVIORAL), Telehealth Physical Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT04923334?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04923334 being conducted?
This trial has 2 study locations across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04923334's enrollment target sits among peer trials
500 18th of 301 higher than 280 of 301 other Chronic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Tele-Collaborative Outreach to Rural Patients With Chronic Pain
RECRUITING · Phase 3
-
CARES-Spine (Comprehensive Analgesic, Recovery, and Education Support for Spine Surgery) Trial
RECRUITING · Phase 3
-
Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits
RECRUITING · Phase 3
-
Efficacy and Safety of Oxymorphone Extended Release in Opioid-Experienced Patients With Chronic Non-Malignant Pain
COMPLETED · Phase 3
-
Digital Therapeutic for Chronic Pain Feasibility Study
COMPLETED · Phase 3
-
An Implantable Spinal Cord Stimulation Pain Management System
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI